Brellium, a New York based provider of an AI-Powered clinical compliance platform, raised $13.7m in Series A funding.
The round was co-led byĀ First Round CapitalĀ andĀ Left Lane Capital, withĀ participation from Menlo Ventures, Digital Health Venture Partners, andĀ Necessary Ventures, alongside a group of angel investors including Andrew Adams (CEO of Headway), Steve Gutentag and Demitri Karagas (co-founders of Thirty Madison), Cory Levy (Z Fellows), and Fiat Ventures.
The company intends to use the funds to grow the team, and accelerate product roadmap.
Led by CEO Zach Rosen, Brellium provides an AI platform for healthcare providers to streamline compliance across millions of patient visits. Clinical teams use it to ensure every patient visit meets payor & clinical quality standards ā without the manual workload. Brellium proactively audits every patient visit, identifying compliance risks before they become problems. Providers then receive instant notifications when charts need corrections, complete with clear instructions on how to fix them.
The company serves healthcare organizations like Grow Therapy, Rula, Headspace, Hopebridge, Lightfully Behavioral Health, Talkiatry, and more.Ā
FinSMEs
21/04/2025